[Nutritional support in non-Hodgkin's lymphoma treated with polychemotherapy MACOP-B cycle].
The collateral effects of antineoplastic therapy often lead to a deterioration of the cachectic condition induced by the presence of the tumour itself. This study analysed the effects of a programme of dietary surveillance/support in patients with non-Hodgkin's lymphoma undergoing a cycle of MACOP-B polychemotherapy. During the entire course of therapy patients were followed weekly by a nutritional specialist and a dietician in order to assess and if necessary modify food intake, also in relation to the onset of collateral effects. Using this programme it was observed that a satisfactory nutritional state was maintained during the entire cycle, with an increased food intake compared to the start of the cycle and to conditions of good health.
Boggio Bertinet
D
D
Servizio di Dietetica e Nutrizione Clinica, USSL VIII - Ospedale Molinette - Torino.
Pezzana
A
A
Vitolo
U
U
Bertini
M
M
Xompero
G
G
Palmo
A
A
Balzola
F
F
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D001835:Body Weight; D003520:Cyclophosphamide / Q000627:therapeutic use; D004032:Diet; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009747:Nutritional Physiological Phenomena; D011239:Prednisolone / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D008727:Methotrexate
Supporto nutrizionale nel linfoma non-Hodgkin in trattamento con ciclo polichemioterapico MACOP-B.